Search

everythinglearnresearchcommunity

for

Search:↓

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Psoriasis and gout are linked, with each increasing the risk of the other.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Omalizumab is generally safe for chronic urticaria, but hair loss is a common side effect.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

SM04755 may be an effective topical treatment for psoriasis.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

A man's gray hair got darker and thicker after using a psoriasis drug.

AGA might indicate higher risk for severe COVID-19.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.